Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome

Current Medical Research and Opinion
Leon SimonsBarry Gumbiner

Abstract

To conduct a post-hoc assessment of the lipid-modifying effects of adding the cholesterol absorption inhibitor, ezetimibe, to on-going statin therapy in patients with diabetes mellitus (DM) or metabolic syndrome (MetS). This was a post-hoc analysis of data from a randomized, double-blind, placebo-controlled trial designed to evaluate the low-density lipoprotein cholesterol (LDL-C)-lowering efficacy and safety of adding ezetimibe 10 mg/day versus placebo to ongoing, open-label statin treatment for 8 weeks in hypercholesterolemic patients. Qualifying LDL-C levels and target LDL-C goals were based on National Cholesterol Education Program risk categories. The DM subgroup were patients who entered the study with a prior diagnosis of DM. Patients were classified as having MetS if they met 3 or more of the following criteria at baseline: triglycerides (TG) > or = 150 mg/dL (1.69 mmol/L); high-density lipoprotein cholesterol (HDL-C) < 40 mg/dL (1.04 mmol/L) for men or < 50 mg/dL (1.29 mmol/L) for women; fasting serum glucose (FSG) > or = 110 mg/dL (> or = 6.1 mmol/L); a diagnosis of hypertension or taking hypertension medication or blood pressure > or = 130/> or = 85 mmHg; waist circumference > 88 cm (women) or > 102 cm (men). DM pati...Continue Reading

References

Jul 1, 1995·Physiological Reviews·G M Reaven
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Apr 27, 2002·Atherosclerosis. Supplements·Guy De Backer, UNKNOWN EUROASPIRE II Study Group
Nov 9, 2002·The American Journal of Cardiology·Claude GagnéUNKNOWN Ezetimibe Study Group
Dec 28, 2002·Diabetes Care·Steven M Haffner, UNKNOWN American Diabetes Association
Dec 31, 2002·Journal of the American College of Cardiology·Michael H DavidsonEnrico P Veltri
Feb 15, 2003·The American Journal of Cardiology·Boris KerznerUNKNOWN Ezetimibe Study Group
Dec 17, 2003·The American Journal of Cardiology·Philip T SagerUNKNOWN Ezetimibe Study Group
Feb 21, 2004·Science·Scott W AltmannMichael P Graziano

❮ Previous
Next ❯

Citations

May 26, 2005·Current Treatment Options in Cardiovascular Medicine·Prakash C Deedwania, Natalia Volkova
Dec 2, 2010·Metabolic Syndrome and Related Disorders·Harold E BaysBarry Gumbiner
Jul 25, 2007·Diabetes, Obesity & Metabolism·A S Wierzbicki
Jul 29, 2010·Lipids in Health and Disease·Carlo M RotellaGian Franco Gensini
Mar 1, 2011·Journal of Geriatric Cardiology : JGC·Hong ShaoJun Xu
Feb 18, 2014·Internal Medicine·Tatsuyori MoritaIchiro Shiojima
Jul 23, 2013·Indian Journal of Endocrinology and Metabolism·Sheelu S SiddiqiAsad U Khan
Nov 16, 2006·Expert Opinion on Therapeutic Targets·Irene F Gazi, Dimitri P Mikhailidis
Apr 12, 2008·Expert Review of Cardiovascular Therapy·Harold E BaysAndrew M Tershakovec
Apr 1, 2006·Current Medical Research and Opinion·Stella S Daskalopoulou, Dimitri P Mikhailidis
Sep 17, 2010·Current Medical Research and Opinion·Maria SarigianniDimitri P Mikhailidis
May 7, 2008·Current Medical Research and Opinion·Steven HildemannChristoph Bode
May 25, 2005·Journal of Internal Medicine·B H R WolffenbuttelUNKNOWN Dutch Corall Study Group
Oct 26, 2005·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·E N LiberopoulosM S Elisaf
Jun 5, 2004·The American Journal of Cardiology·Prakash C DeedwaniaHarold Bays
Apr 20, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Andrea CignarellaChiara Bolego
Nov 18, 2005·International Journal of Cardiology·F D Richard Hobbs
Feb 9, 2012·Postgraduate Medicine·Hari PrasadDwight Stapleton
Oct 25, 2006·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Margo DenkeAndrew M Tershakovec
May 13, 2011·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·John R GuytonPhilippe Brudi
Jul 27, 2007·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Sandra J HamiltonGerald F Watts
May 14, 2005·Expert Review of Cardiovascular Therapy·Prakash Deedwania, Natalia Volkova
Oct 31, 2008·Endocrine Reviews·Marc-Andre CornierRobert H Eckel
Sep 7, 2005·European Heart Journal·Anton F H StalenhoefWim Wilpshaar
Jan 10, 2012·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Michel FarnierAlbert Császár
Aug 24, 2011·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Maurizio AvernaPhilippe Brudi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.